CM
ONXX

Castleark Management’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Castleark Management’s Portfolio ONXX Stock Details ONXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-775
Closed -$67K – 468
2013
Q2 		$67K Buy
+775
New +$71.3K ﹤0.01% 309

Other funds holding ONXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Castleark Management's ONXX Position: Q3 2013 in Review

Castleark Management sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q3 2013, closing a stake of 775 shares — an estimated $67K sold.

Castleark Management first reported a position in ONXX in Q2 2013 and held it in 1 quarter. The position peaked at $67K in Q2 2013. 258 funds tracked by Wall St. Rank hold ONXX as of Q3 2013.

  • Castleark Management reported no remaining ONYX PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Castleark Management sold 775 ONYX PHARMACEUTICALS INC shares in Q3 2013, an estimated $67K.
  • Castleark Management first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Castleark Management's ONYX PHARMACEUTICALS INC position peaked at $67K in Q2 2013.
  • 258 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q3 2013.

Based on Castleark Management's 13F filing for Q3 2013, filed 20 Nov 2013.